Roche extends the tender offer for Spark Therapeutics, Inc.’s shares
By Akshay Kedari  Date: 2019-08-01

Roche extends the tender offer for Spark Therapeutics, Inc.’s shares

The extended tender would provide additional time for the U.S. FTC and U.K. CMA to complete their prior disclosed evaluations of Roche’s acquisition of Spark. 

Swiss healthcare giant, Roche Holding AG have recently announced that it has stretched the offering period of its formerly announced tender offer to purchase all the outstanding shares of common stock of U.S. pharmaceutical company, Spark Therapeutics, Inc. for a reasonable price of $114.50 per share.

According to reliable sources, Citibank, N.A., the depository for the offer, had advised Roche that, as of July 30th, around 9,715,086 shares of Spark had been validly tendered and received, leaving an estimated 25.2% of Spark’s shares as outstanding.

Stockholders who have already given their shares of Spark, do not have to re-tender their shares or take any other action as a result of the extension, suggest reports.

Moreover, closing of the tender offer would depend upon customary closing conditions, including the termination of the valid waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. Meanwhile, MacKenzie Partners, Inc., information agent for the offer would request for documents, while questions regarding the offer would be diverted to the company.

For the record, Spark Therapeutics is a startup pharmaceutical company that is focused on developing, discovering and delivering gene therapies. The company aims on developing medicines for genetic diseases, including blindness, lysosomal storage disorders, haemophilia and neurodegenerative diseases.

As for Roche, it is focused on progressing science to improve people’s health. The availability of diagnostics and pharmaceuticals under one roof has helped Roche become a leader in personalized healthcare. The company is also a frontrunner in diabetes management and a global leader in vitro diagnostics and tissue-based cancer diagnostics.

Headquartered in Basel, Switzerland, the Roche Group is spread over 100 countries with a workforce of about 94,000 employees recorded last year. Additionally, in 2018, Roche invested a total of CHF 11 billion in R&D and managed to record a sale of CHF $56.8 billion, cite sources.

Source Credit: https://www.globenewswire.com/news-release/2019/07/31/1894176/0/en/Roche-and-Spark-Therapeutics-Inc-announce-extension-of-tender-offer-for-shares-of-Spark-Therapeutics-Inc.html

 

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

UV Angel ties up with Smile One Services, launches new dental products
UV Angel ties up with Smile One Services, launches new dental products
By Akshay Kedari

UV Angel, a company renowned in the field of pathogen control technology, has recently announced that it has partnered with Smile One Services, which is dental service organization (DSO)  based in Michigan. Reportedly, the partnership has been i...

LinkedIn Audience Network prefers IAS to offer native ad brand safety
LinkedIn Audience Network prefers IAS to offer native ad brand safety
By Akshay Kedari

Integral Ad Science (IAS), a renowned leader in digital ad verification, has recently announced its agreement with the LinkedIn Audience Network to offer brand safety to native ads on mobile, web, in-app and desktop. The integration tends to utilize ...

SaalexIT acquires Oregon-based Arctic MSP for an undisclosed amount
SaalexIT acquires Oregon-based Arctic MSP for an undisclosed amount
By Akshay Kedari

SaalexIT, a full-service IT company and a market-leading MSSP (Managed Security Service Provider), has reportedly announced its acquisition of Oregon-based Arctic MSP. It is to be noted that the financial terms are yet to be released. The acquisitio...

Virgin Orbit prepares for its first launch mission into the orbit
Virgin Orbit prepares for its first launch mission into the orbit
By Akshay Kedari

Virgin Orbit had recently announced that its LauncherOne air-launched vehicle shall be marking its first flight in the coming days. The company has, however, set modest expectations regarding the probability of success. The company has commented tha...

Cognosante inks acquisition of EIS to expand Federal market offerings
Cognosante inks acquisition of EIS to expand Federal market offerings
By Akshay Kedari

Cognosante, a business process and technology solutions provider, has reportedly announced the acquisition of Vienna-based Enterprise Information Services, LLC. The acquisition of EIS will serve as a growth strategy of the company for expanding its o...